India Cements has received approval for sale of its entire equity investment held in Industrial Chemicals and Monomers (ICML), a subsidiary of the company. Upon completion of the said sale, ICML would cease to be a subsidiary of the company. The said sale/disposal is expected to be completed within a period of six months from the date of agreement. Proposed sale consideration is Rs 97.68 crore. The Board of Directors of the company at its meeting held on June 21, 2025, approved the same.
The India Cements is engaged in the manufacture of products that will enable the customer to build structures which are durable, cost effective and conducive for human life style.